Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Venmax Drugs & PharmaceuticalsBOM:531015 +3.69%33 Days Inventory is 32.25 as of Mar. 2026, which is 83% below its 10-year median of 184.68. GuruFocus rates BOM:531015 with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Venmax Drugs & Pharmaceuticals ranks better than 95.87% on this metric.
The historical rank and industry rank for Venmax Drugs & Pharmaceuticals's Days Inventory or its related term are showing as below:
BOM:531015'
s Days Inventory Range Over the Past 10 Years
Min: 26.41 Med: 184.68 Max: 417.26
Current: 42.57
During the past 13 years, Venmax Drugs & Pharmaceuticals's highest Days Inventory was 417.26. The lowest was 26.41. And the median was 184.68.
BOM:531015's Days Inventory is ranked better than 95.87% of 921
companies
in the Drug Manufacturers industry
Industry Median: 165.24
vs BOM:531015: 42.57
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Venmax Drugs & Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.83.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Venmax Drugs & Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.33.
Venmax Drugs & Pharmaceuticals (BOM:531015) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Venmax Drugs & Pharmaceuticals's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Venmax Drugs & Pharmaceuticals's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Venmax Drugs & Pharmaceuticals Days Inventory Related Terms
Venmax Drugs & Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Venmax Drugs & Pharmaceuticals Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Venmax Drugs & Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Venmax Drugs & Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Venmax Drugs & Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Venmax Drugs & Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Venmax Drugs & Pharmaceuticals (BOM:531015) has a Days Inventory of 32.25 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Venmax Drugs & Pharmaceuticals and its competitors. This is 83% below median its historical median of 184.68. Over the past decade, Venmax Drugs & Pharmaceuticals' Days Inventory has ranged from 26.41 to 417.26. According to the industry distribution chart, Venmax Drugs & Pharmaceuticals ranks #38 out of 921 companies in the Drug Manufacturers industry, placing it in the top 4.1%.
Is Venmax Drugs & Pharmaceuticals' Days Inventory too high?
Venmax Drugs & Pharmaceuticals' current Days Inventory of 32.25 is 83% below median its 10-year median of 184.68. Over the past 10 years, this metric has ranged from a low of 26.41 to a high of 417.26. The Drug Manufacturers industry median Days Inventory is 165.24. Venmax Drugs & Pharmaceuticals' value of 32.25 is 80.5% below this industry median. Based on the distribution chart, Venmax Drugs & Pharmaceuticals ranks #38 out of 921 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Venmax Drugs & Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Venmax Drugs & Pharmaceuticals' Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Venmax Drugs & Pharmaceuticals ranks #38 out of 921 companies for Days Inventory. This places Venmax Drugs & Pharmaceuticals in the top 4% of its industry — outperforming the majority of peers. The industry median Days Inventory is 165.24. Venmax Drugs & Pharmaceuticals' value of 32.25 is 80.5% below this benchmark. Historically, Venmax Drugs & Pharmaceuticals' own Days Inventory has ranged from 26.41 to 417.26 over the past decade. While the company's 10-year median is 184.68 vs. the industry median of 165.24, Venmax Drugs & Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.24, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Venmax Drugs & Pharmaceuticals's current Days Inventory of 32.25 is 80.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Venmax Drugs & Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Venmax Drugs & Pharmaceuticals's current Days Inventory is 32.25, which is 83% below median its own 10-year median of 184.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Venmax Drugs & Pharmaceuticals stock overvalued right now?
Venmax Drugs & Pharmaceuticals (BOM:531015) has a current Days Inventory of 32.25. The current Days Inventory is 32.25, which is 83% below median its 10-year median of 184.68 and 80.5% below the Drug Manufacturers industry median of 165.24. Venmax Drugs & Pharmaceuticals' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Venmax Drugs & Pharmaceuticals (BOM:531015), the current Days Inventory is 32.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Venmax Drugs & Pharmaceuticals Ltd is engaged in the manufacturing and sale of bulk drugs. The company is engaged in the business of IT & ITES services.
33GF Score
Get the complete analysis for BOM:531015
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531015 has been successfully added to your 
